Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication

Journal of Translational Medicine

Volumn 9, Issue 1, 2011, Pages

  Orlandi, Chiara ^a   Forlani, Greta ^a   Tosi, Giovanna ^a   Accolla, Roberto S ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2 TRANSACTIVATOR; NUCLEAR FACTOR; NUCLEAR FACTOR YB; TAX 2 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN; CCAAT BINDING FACTOR; MHC CLASS II TRANSACTIVATOR PROTEIN; NUCLEAR PROTEIN; TAX PROTEIN; TAX PROTEIN, HUMAN T LYMPHOTROPHIC VIRUS 2; TAX PROTEIN, HUMAN T-LYMPHOTROPHIC VIRUS 2; TRANSACTIVATOR PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LYSATE; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; EMBRYO; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 2; IN VIVO STUDY; LONG TERMINAL REPEAT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; VIRUS REPLICATION; CELL FRACTIONATION; CELL STRAIN HEK293; CHEMISTRY; DRUG ANTAGONISM; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; PROTEIN TRANSPORT;

CCAAT-BINDING FACTOR; GENE PRODUCTS, TAX; HEK293 CELLS; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN TRANSPORT; SUBCELLULAR FRACTIONS; TRANS-ACTIVATORS; VIRUS REPLICATION;

EID: 79960644913     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-106     Document Type: Article

References (47)

1. Higuchi M, Fujii M. Distinct function of HTLV-1 Tax1 from HTLV-2 Tax2 contributes key roles to viral pathogenesis. Retrovirology 2009, 6:117-127. 10.1186/1742-4690-6-117, 2806368, 20017952.
2. De Thé G, Kazanji M. An HTLV-I/II vaccine: from animal models to clinical trials?. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13(Suppl 1):S191-198.
3. Feuer G, Green PL. Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene 2005, 24:5996-6004. 10.1038/sj.onc.1208971, 2659530, 16155606.
4. Franchini G. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 1995, 86:3619-3639.
5. Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG. In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol 1990, 64:5682-5687. 248630, 1976827.
6. Casoli C, Cimarelli A, Bertazzoni U. Cellular tropism of human T-cell leukemia virus type II is enlarged to B lymphocytes in patients with high proviral load. Virology 1995, 206:1126-1128. 10.1006/viro.1995.1036, 7531916.
7. Lal RB, Owen SM, Rudolph DL, Dawson C, Prince H. In vivo cellular tropism of human T-lymphotropic virus type II is not restricted to CD8+ cells. Virology 1995, 210:441-447. 10.1006/viro.1995.1360, 7542419.
8. Hoffman PM, Dhib-Jalbut S, Mikovits JA, Robbins DS, Wolf AL, Bergey GK, Lohrey NC, Weislow OS, Ruscetti FW. Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures. Proc Natl Acad Sci USA 1992, 89:11784-11788. 10.1073/pnas.89.24.11784, 50641, 1465399.
9. Poiesz B, Ruscetti F, Gazdar A, Bunn P, Minna J, Gallo R. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980, 77:7415-7419. 10.1073/pnas.77.12.7415, 350514, 6261256.
10. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982, 79:2031-2035. 10.1073/pnas.79.6.2031, 346116, 6979048.
11. Gessain A, Barin F, Vernant J, Gout O, Maurs L, Calender A, de The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985, 2:407-410.
12. Osame M, Usuku K, Izumu S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV-1 associated myelopathy, a new clinical entity. Lancet 1986, 1:1031-1032.
13. Ross TM, Pettiford SM, Green PL. The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes. J Virol 1996, 70:5194-5202. 190475, 8764028.
14. Robek MD, Ratner L. Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J Virol 1999, 73:4856-65. 112529, 10233947.
15. Nerenberg M, Hinrichs SH, Reynolds RK, Khoury G, Jay G. The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science 1987, 237:1324-1329. 10.1126/science.2888190, 2888190.
16. Hasegawa H, Sawa H, Lewis MJ, Orba Y, Sheehy N, Yamamoto Y, Ichinohe T, Tsunetsugu-Yokota Y, Katano H, Takahashi H, Matsuda J, Sata T, Kurata T, Nagashima K, Hall WW. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat Med 2006, 12:466-472. 10.1038/nm1389, 16550188.
17. Matsuoka M, Jeang K-T. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ, and therapy. Oncogene 2011, 30:1379-1389. 10.1038/onc.2010.537, 21119600.
18. Greene WC, Leonard WJ, Wano Y, Svetlik PB, Peffer NJ, Sodroski JG, Rosen CA, Goh WC, Haseltine WA. Trans-activator gene of HTLV-II induces IL-2 receptor and IL-2 cellular gene expression. Science 1986, 16:877-880.
19. Ballard DW, Böhnlein E, Lowenthal JW, Wano Y, Franza BR, Greene WC. HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science 1988, 23:1652-1655.
20. Yoshida M. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 2005, 5:5931-5937.
21. Casoli C, De Lerma Barbaro A, Pilotti E, Bertazzoni U, Tosi G, Accolla RS. The MHC class II transcriptional activator (CIITA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2. Blood 2004, 103:995-1001.
22. Tosi G, Pilotti E, Mortara L, De Lerma Barbaro A, Casoli C, Accolla RS. Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y. Proc Natl Acad Sci 2006, 103:12861-12866. 10.1073/pnas.0601589103, 1568938, 16908858.
23. Accolla RS, De Lerma Barbaro A, Mazza S, Casoli C, De Maria A, Tosi G. The MHC class II transactivator: prey and hunter in infectious diseases. Trends Immunol 2001, 22:560-563. 10.1016/S1471-4906(01)02003-8, 11574280.
24. Accolla RS, Mazza S, De Lerma Barbaro A, De Maria A, Tosi G. The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication. Eur J Immunol 2002, 32:2783-2791. 10.1002/1521-4141(2002010)32:10<2783::AID-IMMU2783>3.0.CO;2-E, 12355430.
25. Accolla RS, Jottrand-Bellomo M, Scarpellino L, Maffei A, Carra G, Guardiola J. aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression. J Exp Med 1986, 164:369-374. 10.1084/jem.164.1.369, 2188193, 3088202.
26. Steimle V, Otten LA, Zufferey M, Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 1993, 75:135-146.
27. Reith W, LeibundGut-Landmann S, Waldburger JM. Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol 2005, 5:703-806.
28. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994, 76:287-299. 10.1016/0092-8674(94)90336-0, 8293464.
29. Caretti G, Cocchiarella F, Sidoli C, Villard J, Peretti M, Reith W, Mantovani R. Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoter. Mol Biol 2000, 302:539-552.
30. De Sandro AM, Nagarajan UM, Boss JM. Associations and interactions between bare lymphocyte syndrome factors. Mol Cell Biol 2000, 20:6587-6599. 10.1128/MCB.20.17.6587-6599.2000, 86141, 10938133.
31. Masternak K, Muhlethaler-Mottet A, Villard J, Zufferey M, Steimle V, Reith W. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev 2000, 14:1156-1166. 316580, 10809673.
32. Zhu XS, Linhoff M W, Li G, Chin K, Ting JPY. Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter. Mol Cell Biol 2000, 20:6051-6064. 10.1128/MCB.20.16.6051-6061.2000, 86081, 10913187.
33. Jabrane-Ferrat N, Nekrep N, Tosi G, Esserman L, Peterlin BM. Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor × (RFX) on DNA requires RFX5 dimers. Mol Cell Biol 2002, 22:5616-5625. 10.1128/MCB.22.15.5616-5625.2002, 133954, 12101253.
34. Jabrane-Ferrat N, Nekrep N, Tosi G, Peterlin BM. MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators?. Int Immunol 2003, 15:467-475. 10.1093/intimm/dxg048, 12663676.
35. Kretsovali A, Agalioti T, Spilianakis C, Tzortzakaki E, Merika M, Papamatheakis J. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator. Mol Cell Biol 1998, 18:6777-6783. 109261, 9774691.
36. Fontes JD, Kanazawa S, Jean D, Peterlin BM. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol Cell Biol 1999, 19:941-947. 83952, 9858618.
37. Spilianakis C, Papamatheakis J, Kretsovali A. Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes. Mol Cell Biol 2000, 20:8489-8498. 10.1128/MCB.20.22.8489-8498.2000, 102155, 11046145.
38. Kanazawa S, Takashi O, Peterlin BM. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity 2000, 12:61-70. 10.1016/S1074-7613(00)80159-4, 10661406.
39. Wei P, Garber ME, Fang SM, Fisher WH, Jones KA. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998, 92:451-462. 10.1016/S0092-8674(00)80939-3, 9491887.
40. Tosi G, Jabrane-Ferrat N, Peterlin BM. Phosphorylation of CIITA directs its oligomerization, accumulation and increased activity on MHCII promoters. EMBO J 2002, 21:5467-5476. 10.1093/emboj/cdf557, 129089, 12374747.
41. Harton JA, O'Connor W, Conti BJ, Linhoff MW, Ting JPY. Leucine-rich repeats of the class II transactivator control its rate of nuclear accumulation. Hum Immunol 2002, 63:588-601. 10.1016/S0198-8859(02)00400-7, 12072194.
42. Cressman DE, O'Connor WJ, Greer SF, Zhu XS, Ting JPY. Mechanisms of nuclear import and export that control the subcellular localization of class II transactivator. J Immunol 2001, 167:3626-3634.
43. Chevalier SA, Meertens L, Calattini S, Gessain A, Kiemer L, Mahieux R. Presence of a functional but dispensable nuclear export signal in the HTLV-2 Tax protein. Retrovirology 2005, (2):70-79.
44. Meertens L, Chevalier S, Weil R, Gessain A, Mahieux R. A 10-amino acid domain within human T-cell leukemia virus type 1 and type 2 tax protein sequences is responsible for their divergent subcellular distribution. J Biol Chem 2004, 279:43307-43320. 10.1074/jbc.M400497200, 15269214.
45. Avesani F, Romanelli MG, Turci M, Di Gennaro G, Sampaio C, Bidoia C, Bertazzoni U, Bex F. Association of HTLV Tax proteins with TAK1-binding protein 2 and RelA in calreticulin-containing cytoplasmic structures participates in Tax-mediated NF-κB activation. Virology 2010, 408:39-48. 10.1016/j.virol.2010.08.023, 20875659.
46. Alefantis T, Barmak K, Harhaj EW, Grant C, Wigdahl B. Characterization of a nuclear export signal within the human T cell leukemia virus type I transactivator protein Tax. J Biol Chem 2003, 278:21814-21822. 10.1074/jbc.M211576200, 12670929.
47. Kahle J, Baake M, Doenecke D, Albig W. Subunits of the heterotrimeric transcription factor NF-Y are imported into the nucleus by distinct pathways involving importin beta and importin 13. Mol Cell Biol 2005, (25):5339-5354.